From: Elaboration of a nomogram to predict nonsentinel node status in breast cancer patients with positive sentinel node, intraoperatively assessed with one step nucleic amplification: Retrospective and validation phase
Risk Categories
11%
20%
30%
45%
50%
31%
% False negative (FN)
1%
3.5%
8.2%
18.4%
24.4%
8.9%
% False positive FP)
56.0%
45.6%
31.4%
15.6%
9.0%
30.1%